George Frangeskides, Exec-Chair at Alba Mineral Resources, discusses grades at the Clogau Gold Mine. Watch the full video here.
surely this comment is a joke...
"We are looking forward to beginning to produce significant volumes of CoalSwitch to meet the indicative international demand we are seeing."
they cant even produce any new coalswitch just now let alone significant volume.
and on page 23 within the table on point 59 it states sept 2022 for CNEL.
and 0308966 we were suspended in april so its been less than 12 months for the new rule changes which means we still have 18 months as described in part 5c.
im hoping that we wont even come close to that date and be listed again in next few weeks.
its always been 18months even detailed in previous RNS
https://www1.hkexnews.hk/listedco/listconews/sehk/2021/0507/2021050701339.pdf
lets hope your right topm, and we see some news this week and finally are a step closer to returning back to market.
thanks nick, doesnt look like we'll return to market any time soon then!
anyone got a link for this? i had a look over the ztky website and cant see any news in the news tab.
agreed researcher, after 52 peer reviews some from the top and best cancer research facilities in the world all demostrating parsortix albility to harvest live CTC's will back up Andrews statements on how parsortix works. you cant deny facts and the research papers to back up Angles claim.
will the theranos scam delay FDAs approval? highly unlikely in my eyes. they have all the data and will base their decision on this not what other companies do. the delay in my eyes will purely be down to the covid delay that we all know of.
crispiano it should reflect on SP. there is more of an appetite for tech stocks/ med tech stocks on the nasdaq, there is also more avenues for fundraising which should grow the company faster. Also a wider investment market where across the pond where the US investors struggle to buy shares in AGL without going through the off market (OTC/pink sheet)
you could agrue that there is a better chance of partnerships and mergers/buyouts if already listed on nasdaq where the merger/buyout is from a US listed company. all the big pharma money is from nasdaq listed companies.
while listed on the aim market it may hold back growth, i believe the nasdaq would open a lot more doors and quicker to justify a higher SP
so in short answer is a reflection on SP which should be higher
the problem with the wording theyve never gave a date always used phrases like aiming to deliver headline news in Q4 etc.
i would like to hear some news on that front this side of the year but wouldnt be surprised if it rolled into january for news, would be a nice boost going into the end of the year but im willing to wait it out. i for one wont be trying to play the swing and sell to get in lower pre news. ill just let it ride and enjoy that red dot when it comes.
ive been in a few companies whos delisted from aim markets before. delisting doesnt mean the BOD loose. it bascailly turns the company private meaning its not traded on any market. yes in theory you still own a part of the company but without a means to sell or transfer your shares then your stuck with worthless stock without any means to sell them unless you can find a way to do it privately whoch is highly unlikey. fhe BOD do not need to sort out a share transfer vechile of some kind. all it will mean is they will loose the paths for easy finanace. but if cnel is supported by their own profits they wouldnt need to look for finance. obv the big shareholders wont loose out its only the small pi's that will take the hit.
im not saying that delisting will come. i still live in hope but i wont go in with tunnel vision, after being burned before from poorly managed companies i understand the risks. lets see if they can get out of this **** show theyve created.
well they better release something soon. come september they will be delisted and we loose everything. as each month passes that seems a more likely senario. lets hope the BOD get their finger out and start pushing the company forward instead of digging an early grave for it.
theres been huge double trades going through for weeks now. usually with same time stamp on them. theres a massive transfer of shares from a seller to a buyer, hence why the sp hasnt moved too much. if the grey/unknown shares are the big numbered trades i wouldnt look too much into it. until the transfer is complete they will keep coming and wont effect the sp until the orders have been filled.
cabbie 139/140p is the big resistance to punch through. once broken there could be a sharp move into the 150s then soon after 160s. and all of that could happen pre fda news possibly even before ovrian news but that news might be needed to push past 160s.
close to breaking out dibs, mm's have been keeping a lid on price for the past week ranging very closely between 134-136p.
huge transfer going on in the background of some kind as price hasn't moved and big trades keep popping up. either going to break up or fall back down but im sensing a quick move up and once we break 140p then we should move up very quickly.
sit above 150p pre news is a great launch pad for the up and coming news
thanks for the update guys. no idea how the HK will react when we return to market. will there be a big sell off by ****ed off investors or will CNEL finally get the ball rolling with new updates on contracts and revenue? doubt it... ill take a steady sp on reslisting without the arse falling out of it.